First full length rabbit sourced mAb approved by FDA

FDA approved the listing of Eptinezumab, a CGRP antibody of Danish Lundbeck pharmaceutical, under the trade name of Vyepti, to prevent migraine On February 22, 2022. Since 1986, FDA has approved more than 90 new monoclonal antibody...